Statements (51)
Predicate | Object |
---|---|
gptkbp:instanceOf |
Cell
|
gptkbp:canBe |
multipotent
pluripotent totipotent unipotent |
gptkbp:canBeCulturedIn |
gptkb:research_institute
|
gptkbp:canBeGeneticallyModified |
for research
|
gptkbp:canBeTransplanted |
into patients
|
gptkbp:canDifferentiateInto |
specialized cell types
|
gptkbp:derivedFrom |
adipose tissue
bone marrow embryos umbilical cord blood skin cells (via reprogramming) |
gptkbp:discoveredBy |
gptkb:Ernst_Haeckel
|
gptkbp:firstHumanEmbryonicStemCellIsolatedBy |
gptkb:James_Thomson
|
gptkbp:firstHumanEmbryonicStemCellIsolatedInYear |
1998
|
gptkbp:firstIsolatedFrom |
gptkb:mouse
|
gptkbp:firstIsolatedInYear |
1981
|
gptkbp:form |
organoids
|
gptkbp:foundIn |
multicellular organisms
|
gptkbp:hasAbility |
differentiation
self-renewal |
https://www.w3.org/2000/01/rdf-schema#label |
Stemcell
|
gptkbp:marking |
gptkb:Sox2
gptkb:Nanog gptkb:Oct4 |
gptkbp:regulates |
government policies
signaling pathways |
gptkbp:studiedBy |
research institutes
universities medical scientists biologists pharmaceutical companies |
gptkbp:studiedIn |
developmental biology
|
gptkbp:subjectOf |
ethical debate
|
gptkbp:type |
embryonic stem cell
adult stem cell induced pluripotent stem cell perinatal stem cell |
gptkbp:usedFor |
drug discovery
disease modeling tissue repair |
gptkbp:usedIn |
research
regenerative medicine stem cell therapy |
gptkbp:usedInTreatmentOf |
gptkb:anemia
leukemia immune system disorders |
gptkbp:bfsParent |
gptkb:BOSH
|
gptkbp:bfsLayer |
7
|